Doximity (DOCS) Cash & Equivalents (2021 - 2026)

Doximity (DOCS) has 6 years of Cash & Equivalents data on file, last reported at $219.2 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $219.2 million, up 4.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $219.2 million (up 4.56% YoY), and the FY2026 annual result was $219.2 million, up 4.56% from the prior year.
• Cash & Equivalents improved to $219.2 million in Q1 2026 per DOCS's latest filing, from $64.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $306.7 million in Q2 2023 and troughed at $64.8 million in Q4 2025.
• A 5-year average of $146.3 million and a median of $136.5 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 81.48% in 2022, then jumped 178.61% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $136.5 million in 2022, then slipped by 9.79% to $123.1 million in 2023, then jumped by 34.27% to $165.3 million in 2024, then plunged by 60.77% to $64.8 million in 2025, then surged by 238.04% to $219.2 million in 2026.
• Business Quant data shows DOCS's Cash & Equivalents at $219.2 million in Q1 2026, $64.8 million in Q4 2025, and $169.2 million in Q3 2025.